Connect public, paid and private patent data with Google Patents Public Datasets

Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen

Info

Publication number
DE69838553D1
DE69838553D1 DE1998638553 DE69838553A DE69838553D1 DE 69838553 D1 DE69838553 D1 DE 69838553D1 DE 1998638553 DE1998638553 DE 1998638553 DE 69838553 A DE69838553 A DE 69838553A DE 69838553 D1 DE69838553 D1 DE 69838553D1
Authority
DE
Grant status
Grant
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1998638553
Other languages
English (en)
Other versions
DE69838553T2 (de )
Inventor
Thai D Nguyen
Jon R Polansky
Pu Chen
Hua Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
DE1998638553 1997-01-28 1998-01-09 Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen Expired - Fee Related DE69838553D1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US79115497 true 1997-01-28 1997-01-28
US08938669 US6171788B1 (en) 1997-01-28 1997-09-26 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
PCT/US1998/000468 WO1998032850A1 (en) 1997-01-28 1998-01-09 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

Publications (1)

Publication Number Publication Date
DE69838553D1 true DE69838553D1 (de) 2007-11-22

Family

ID=27121110

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1998638553 Expired - Lifetime DE69838553T2 (de) 1997-01-28 1998-01-09 Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
DE1998638553 Expired - Fee Related DE69838553D1 (de) 1997-01-28 1998-01-09 Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1998638553 Expired - Lifetime DE69838553T2 (de) 1997-01-28 1998-01-09 Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen

Country Status (6)

Country Link
US (1) US6171788B1 (de)
JP (1) JP2001509669A (de)
CA (1) CA2278782C (de)
DE (2) DE69838553T2 (de)
EP (1) EP1012271B1 (de)
WO (1) WO1998032850A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956103B2 (en) 1994-04-28 2005-10-18 The University Of Iowa Research Foundation Glaucoma therapeutics and diagnostics
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) * 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) * 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6403307B1 (en) * 1997-03-21 2002-06-11 University Of Iowa Research Foundation Glaucoma therapeutics and diagnostics
JP2002306165A (ja) * 2000-05-17 2002-10-22 Yukio Hattori 正常眼圧緑内障を含む開放隅角緑内障の関連遺伝子
US20020168639A1 (en) * 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
US6727354B2 (en) * 2001-12-12 2004-04-27 Quest Diagnostics Investments, Inc. Compositions and methods for TIGR genotyping assays

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
WO1982001011A1 (en) 1980-09-24 1982-04-01 Corp Cetus Diagnostic method and probe
EP0052510B2 (de) 1980-11-18 1994-10-19 Syntex (U.S.A.) Inc. Mikroverkapslung wasserlöslicher Polypeptide
DE3273501D1 (de) 1981-02-16 1986-11-06 Ici Plc Continuous release pharmaceutical compositions
US4582788A (en) 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
DE3381518D1 (de) 1982-01-22 1990-06-07 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
JPS59199000A (en) 1983-02-28 1984-11-10 Akutagen Inc Determination of master system and establishment of indivisual hereditary identity
US4617299A (en) 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
DE3413608A1 (de) 1984-04-11 1985-10-24 Hoechst Ag Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
US4683194A (en) 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
US4683202B1 (de) 1985-03-28 1990-11-27 Cetus Corp
US4757089A (en) 1985-06-14 1988-07-12 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
CA1284931C (en) 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
GB8606719D0 (en) 1986-03-19 1986-04-23 Lister Preventive Med Genetic probes
DE3612537C1 (de) 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
CA1338457C (en) 1986-08-22 1996-07-16 Henry A. Erlich Purified thermostable enzyme
ES2009286A6 (es) 1987-06-19 1989-09-16 Siska Diagnostics Inc Metodos para preparar acido nucleico bicatenario con una secuencia objetivo, detectar dicha secuencia y multiplicar un segmento de acido nucleico objetivo, y estuche de deteccion correspondiente.
DE68908054D1 (de) 1988-01-21 1993-09-09 Genentech Inc Verstaerkung und nachweis von nukleinsaeuresequenzen.
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
ES2012634A6 (es) 1988-02-08 1990-04-01 Insite Vision Inc Un sistema de suministro de un medicamento oftalmico administrable porvia topica y metodo correspondiente.
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5190762A (en) 1988-07-06 1993-03-02 Applied Genetics, Inc. Method of administering proteins to living skin cells
WO1990001069A1 (en) 1988-07-20 1990-02-08 Segev Diagnostics, Inc. Process for amplifying and detecting nucleic acid sequences
GB8926026D0 (en) 1988-11-25 1990-01-10 Ici Plc Extended nucleotide sequences
DE69029726D1 (de) 1989-03-22 1997-02-27 Cemu Bioteknik Ab Festphasendiagnose von medizinischen konditionen
US5075217A (en) 1989-04-21 1991-12-24 Marshfield Clinic Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences
WO1990013668A1 (en) 1989-05-05 1990-11-15 Lifecodes Corporation Method for genetic analysis of a nucleic acid sample
WO1991005771A1 (en) 1989-10-13 1991-05-02 Hans Schreier Lipophilic acylpyrazinamide prodrugs
US5124154A (en) 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5270052A (en) 1991-04-19 1993-12-14 New England Medical Center Hospitals, Inc. Methods and compositions for treatment of infection by intracellular parasites
US5169766A (en) 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
WO1993012234A1 (en) 1991-12-13 1993-06-24 Sri International Antiviral reagents based on rna-binding proteins
JPH08502244A (ja) 1992-08-11 1996-03-12 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫調節ペプチド
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5474985A (en) 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5916778A (en) 1994-04-28 1999-06-29 University Of Iowa Research Foundation Diagnostics based on a glaucoma causing gene
US5925748A (en) 1994-04-28 1999-07-20 The University Of Iowa Research Foundation DNA diagnostics for glaucoma
WO1998020131A1 (en) 1996-11-08 1998-05-14 University Of Iowa Research Foundation Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
US5789169A (en) 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
FR2733251B1 (fr) 1995-04-18 1997-07-04 Inst Nat Sante Rech Med Depistage du glaucome juvenile
US5674888A (en) 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US5885776A (en) 1997-01-30 1999-03-23 University Of Iowa Research Foundation Glaucoma compositions and therapeutic and diagnositic uses therefor
CA2216997A1 (en) 1997-09-30 1999-03-30 Jean Morissette Molecular diagnostic of glaucomas associated with chromosomes 1
WO1999016898A1 (en) 1997-09-30 1999-04-08 Universite Laval Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof

Also Published As

Publication number Publication date Type
CA2278782C (en) 2004-05-25 grant
US6171788B1 (en) 2001-01-09 grant
EP1012271B1 (de) 2007-10-10 grant
EP1012271A1 (de) 2000-06-28 application
WO1998032850A1 (en) 1998-07-30 application
DE69838553T2 (de) 2008-07-03 grant
JP2001509669A (ja) 2001-07-24 application
CA2278782A1 (en) 1998-07-30 application

Similar Documents

Publication Publication Date Title
DE69534505T2 (de) Verfahren zur herstellung von medizinischen vorrichtungen; intravaskulärokklusionsvorrichtung
DE29711727U1 (de) Kopforthese zur Behandlung von Schädeldeformitäten
DE29710665U1 (de) Liege für die humanmedizinische Behandlung
DE69707033T2 (de) Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten
DE69022269T2 (de) Verfahren zur thermischen Behandlung von Silizium.
DE69427897T2 (de) Verfahren zur Behandlung von kontaminierten Sedimenten
DE9421606U1 (de) Vorrichtung zur extrakorporalen Behandlung von Blut
DE69608682T2 (de) Verfahren zur diagnose von schizophrenie
DE69832022D1 (de) System zur Behandlung von Neurologischen Krankheiten
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE60131393D1 (de) Verfahren zur behandlung von erkrankungen assoziiert mit akuten entzündung unter nichtischämischen zustände
DE69617047D1 (de) Anordnung zur behandlung der haut
DE69526344D1 (de) Stabilgelzusammensetzung zur topischen behandlung von hautkrankheiten
DE69702747T2 (de) Methode zur behandlung von poyamidmembranen um den fluss zu erhöhen
DE69327582T2 (de) Methoden zur Behandlung von Interleukin- 1 und - Tumor - Nekrose - Faktor - verursachten Krankheiten
DE69943107D1 (de) Behandlung von autoimmunerkrankungen
DE69609082T2 (de) Verfahren zur behandlung von abfällen
DE59000141D1 (de) Verfahren zur isolierung des blutgerinnungsfaktors ix.
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
DE68917678T2 (de) Verfahren und Mittel zur Behandlung der Alzheimer-Krankheit, verwandter Demenzen und Epilepsie.
DE69621232T2 (de) Vorrichtung zur hyperthermie-behandlung
DE69629188D1 (de) Verwendung von (r)-penciclovirtriphosphat zur herstellung eines arzneimittels zur behandlung von viruserkrankungen
DE69722630D1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
DE69735162D1 (de) L-carnosin enthaltende mittel zur behandlung des nierenversagens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee